Search

everythinglearnresearchcommunity

for

Search:↓

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Simpler treatments and better drug delivery improve acne and rosacea outcomes.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Physicians often overlook patients' use of alternative medicine for psoriasis, highlighting a need for better communication.

Patients felt happier with their looks and younger after hair transplant surgery, but their well-being and social life didn't change much.

Patients with renal disease should be cautious with vitamin A supplements due to risk of toxicity.

Patients with alopecia areata face high costs for wigs due to poor insurance coverage.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Patients with mycosis fungoides have a higher risk of heart disease.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

Alopecia areata significantly affects emotional well-being and daily activities, suggesting a need for patient-centered care.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

Patients with Alopecia Areata often have higher anxiety and depression.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The hair fiber filler product increased satisfaction and improved quality of life for people with thinning hair.

Endoscopic brow-lift is effective and well-tolerated, with high patient satisfaction and improved appearance.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Empathy and better training for doctors are needed to improve alopecia care.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Alopecia areata negatively impacts quality of life and work, even with moderate hair loss.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.